These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16206504)
1. Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States. Burton JR; Rosen HR Clin Gastroenterol Hepatol; 2005 Jul; 3(7):700-4. PubMed ID: 16206504 [TBL] [Abstract][Full Text] [Related]
3. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Burton JR; Sonnenberg A; Rosen HR Liver Transpl; 2004 Oct; 10(10 Suppl 2):S59-64. PubMed ID: 15382221 [TBL] [Abstract][Full Text] [Related]
4. To transplant or not to transplant recurrent hepatitis C and liver failure. Forman LM Clin Liver Dis; 2003 Aug; 7(3):615-29. PubMed ID: 14509530 [TBL] [Abstract][Full Text] [Related]
5. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey. Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258 [TBL] [Abstract][Full Text] [Related]
6. Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis. Njei B; McCarty TR; Fortune BE; Lim JK Aliment Pharmacol Ther; 2016 Nov; 44(10):1090-1101. PubMed ID: 27640785 [TBL] [Abstract][Full Text] [Related]
7. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study. Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099 [TBL] [Abstract][Full Text] [Related]
8. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence. Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164 [TBL] [Abstract][Full Text] [Related]
9. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581 [TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484 [TBL] [Abstract][Full Text] [Related]
12. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835 [TBL] [Abstract][Full Text] [Related]
13. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896 [TBL] [Abstract][Full Text] [Related]
14. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. McCashland T; Watt K; Lyden E; Adams L; Charlton M; Smith AD; McGuire BM; Biggins SW; Neff G; Burton JR; Vargas H; Donovan J; Trotter J; Faust T Liver Transpl; 2007 Sep; 13(9):1246-53. PubMed ID: 17763405 [TBL] [Abstract][Full Text] [Related]
15. Risk factors in liver retransplantation: a single-center experience. Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065 [TBL] [Abstract][Full Text] [Related]
16. Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis. Bangaru S; Pedersen MR; MacConmara MP; Singal AG; Mufti AR Liver Transpl; 2018 Oct; 24(10):1357-1362. PubMed ID: 30141270 [TBL] [Abstract][Full Text] [Related]
17. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Wali M; Harrison RF; Gow PJ; Mutimer D Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889 [TBL] [Abstract][Full Text] [Related]
18. Natural history of hepatitis C and outcomes following liver transplantation. Rodriguez-Luna H; Vargas HE Minerva Gastroenterol Dietol; 2004 Mar; 50(1):51-9. PubMed ID: 15719006 [TBL] [Abstract][Full Text] [Related]
19. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061 [TBL] [Abstract][Full Text] [Related]
20. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome. Yoo HY; Maheshwari A; Thuluvath PJ Liver Transpl; 2003 Sep; 9(9):897-904. PubMed ID: 12942450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]